Pharsight to Support FDA s Critical Path Initiative

Jun 07, 2006

NEW YORK, June 7 (GenomeWeb News) - Pharsight has entered into a Cooperative Research and Development Agreement with the US Food and Drug Administration's Center for Drug Evaluation and Research, the firms said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

CRISPR Stakeholders Seek Reversal of Patent Interference Proceeding Decision
Thermo Fisher Scientific Q2 Revenues Up 10 Percent; Firm Increases 2017 Guidance Again
Adaptive Biotechnologies, NCI Collaborate on Immunosequencing Biomarker Discovery
Gastric Cancer Subtypes Found to Have Different Prognoses
UPDATE: LabCorp Q2 Revenues Rise 5 Percent, Fueled by Diagnostics Growth
Exact Sciences Q2 Revenues Up 172 Percent

The Scan

Cloud Ready

CNBC reports that Amazon invested in the startup Grail as it sees it as opportunity for its cloud computing company in genomics.

The Science and Policy Connection

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

The New Yeast

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

This Week in Cell

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.

Main menu